241 related articles for article (PubMed ID: 30704863)
1. Cross-diagnostic analysis of cognitive control in mental illness: Insights from the CNTRACS consortium.
Smucny J; Barch DM; Gold JM; Strauss ME; MacDonald AW; Boudewyn MA; Ragland JD; Silverstein SM; Carter CS
Schizophr Res; 2019 Jun; 208():377-383. PubMed ID: 30704863
[TBL] [Abstract][Full Text] [Related]
2. Executive deficits in psychotic and bipolar disorders - implications for our understanding of schizoaffective disorder.
Szoke A; Meary A; Trandafir A; Bellivier F; Roy I; Schurhoff F; Leboyer M
Eur Psychiatry; 2008 Jan; 23(1):20-5. PubMed ID: 18083013
[TBL] [Abstract][Full Text] [Related]
3. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].
Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D
Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195
[TBL] [Abstract][Full Text] [Related]
4. Neurocognition in patients with psychotic and non-psychotic bipolar I disorder. A comparative study with individuals with schizophrenia.
Jiménez-López E; Aparicio AI; Sánchez-Morla EM; Rodriguez-Jimenez R; Vieta E; Santos JL
J Affect Disord; 2017 Nov; 222():169-176. PubMed ID: 28709024
[TBL] [Abstract][Full Text] [Related]
5. Schizotypal personality traits and social cognition are associated with childhood trauma exposure.
Quidé Y; Cohen-Woods S; O'Reilly N; Carr VJ; Elzinga BM; Green MJ
Br J Clin Psychol; 2018 Nov; 57(4):397-419. PubMed ID: 29923348
[TBL] [Abstract][Full Text] [Related]
6. Psychosocial functioning in patients with psychotic and non-psychotic bipolar I disorder. A comparative study with individuals with schizophrenia.
Jiménez-López E; Sánchez-Morla EM; Aparicio AI; López-Villarreal A; Martínez-Vizcaíno V; Rodriguez-Jimenez R; Vieta E; Santos JL
J Affect Disord; 2018 Mar; 229():177-185. PubMed ID: 29316520
[TBL] [Abstract][Full Text] [Related]
7. Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders.
Reichenberg A; Harvey PD; Bowie CR; Mojtabai R; Rabinowitz J; Heaton RK; Bromet E
Schizophr Bull; 2009 Sep; 35(5):1022-9. PubMed ID: 18495643
[TBL] [Abstract][Full Text] [Related]
8. Examining cognition across the bipolar/schizophrenia diagnostic spectrum.
Lynham AJ; Hubbard L; Tansey KE; Hamshere ML; Legge SE; Owen MJ; Jones IR; Walters JTR
J Psychiatry Neurosci; 2018 Jul; 43(4):245-253. PubMed ID: 29947606
[TBL] [Abstract][Full Text] [Related]
9. Levels of Cognitive Control: A Functional Magnetic Resonance Imaging-Based Test of an RDoC Domain Across Bipolar Disorder and Schizophrenia.
Smucny J; Lesh TA; Newton K; Niendam TA; Ragland JD; Carter CS
Neuropsychopharmacology; 2018 Feb; 43(3):598-606. PubMed ID: 28948978
[TBL] [Abstract][Full Text] [Related]
10. Specific and generalized neuropsychological deficits: a comparison of patients with various first-episode psychosis presentations.
Zanelli J; Reichenberg A; Morgan K; Fearon P; Kravariti E; Dazzan P; Morgan C; Zanelli C; Demjaha A; Jones PB; Doody GA; Kapur S; Murray RM
Am J Psychiatry; 2010 Jan; 167(1):78-85. PubMed ID: 19952077
[TBL] [Abstract][Full Text] [Related]
11. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
Jabben N; Arts B; van Os J; Krabbendam L
J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
[TBL] [Abstract][Full Text] [Related]
12. The impact of a history of psychotic symptoms on cognitive function in euthymic bipolar patients: a comparison with schizophrenic patients and healthy controls.
Brissos S; Dias VV; Soeiro-de-Souza MG; Balanzá-Martínez V; Kapczinski F
Braz J Psychiatry; 2011 Dec; 33(4):353-61. PubMed ID: 22189924
[TBL] [Abstract][Full Text] [Related]
13. Predicting psychosis across diagnostic boundaries: Behavioral and computational modeling evidence for impaired reinforcement learning in schizophrenia and bipolar disorder with a history of psychosis.
Strauss GP; Thaler NS; Matveeva TM; Vogel SJ; Sutton GP; Lee BG; Allen DN
J Abnorm Psychol; 2015 Aug; 124(3):697-708. PubMed ID: 25894442
[TBL] [Abstract][Full Text] [Related]
14. Is cognitive enhancement therapy equally effective for patients with schizophrenia and schizoaffective disorder?
Lewandowski KE; Eack SM; Hogarty SS; Greenwald DP; Keshavan MS
Schizophr Res; 2011 Feb; 125(2-3):291-4. PubMed ID: 21167689
[TBL] [Abstract][Full Text] [Related]
15. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
16. Could schizoaffective disorder, schizophrenia and bipolar I disorder be distinguishable using cognitive profiles?
Chen CK; Lee CY; Lee Y; Hung CF; Huang YC; Lee SY; Huang MC; Chong MY; Chen YC; Wang LJ
Psychiatry Res; 2018 Aug; 266():79-84. PubMed ID: 29852325
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal stability of cognitive control in early psychosis: Nondegenerative deficits across diagnoses.
Smucny J; Lesh TA; Iosif AM; Niendam TA; Tully LM; Carter CS
J Abnorm Psychol; 2018 Nov; 127(8):781-788. PubMed ID: 29781657
[TBL] [Abstract][Full Text] [Related]
18. Deficits in visual sustained attention differentiate genetic liability and disease expression for schizophrenia from Bipolar Disorder.
Kumar CT; Christodoulou T; Vyas NS; Kyriakopoulos M; Corrigall R; Reichenberg A; Frangou S
Schizophr Res; 2010 Dec; 124(1-3):152-60. PubMed ID: 20674278
[TBL] [Abstract][Full Text] [Related]
19. Neuropsychological functioning in bipolar disorder and schizophrenia.
Schretlen DJ; Cascella NG; Meyer SM; Kingery LR; Testa SM; Munro CA; Pulver AE; Rivkin P; Rao VA; Diaz-Asper CM; Dickerson FB; Yolken RH; Pearlson GD
Biol Psychiatry; 2007 Jul; 62(2):179-86. PubMed ID: 17161829
[TBL] [Abstract][Full Text] [Related]
20. Functional outcome and service engagement in major depressive disorder with psychotic features: comparisons with schizophrenia, schizoaffective disorder and bipolar disorder in a 6-year follow-up of the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS).
Kingston T; Scully PJ; Browne DJ; Baldwin PA; Kinsella A; O'Callaghan E; Russell V; Waddington JL
CNS Neurosci Ther; 2018 Jul; 24(7):633-640. PubMed ID: 29575682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
